LEADER 04217nam 2200613 450 001 9910464437103321 005 20200520144314.0 010 $a0-309-28283-7 035 $a(CKB)3710000000103424 035 $a(EBL)3379290 035 $a(SSID)ssj0001064984 035 $a(PQKBManifestationID)11599251 035 $a(PQKBTitleCode)TC0001064984 035 $a(PQKBWorkID)11054213 035 $a(PQKB)10594148 035 $a(MiAaPQ)EBC3379290 035 $a(Au-PeEL)EBL3379290 035 $a(CaPaEBR)ebr10863948 035 $a(OCoLC)880438337 035 $a(EXLCZ)993710000000103424 100 $a20131211h20132013 uy| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aInterim report of the Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care $epreliminary committee observations /$fCommittee on Geographic Variation in Health Care Spending and Promotion of High-Value Care, Board on Health Care Services ; Joseph P. Newhouse [and five others], editors ; Institute of Medicine of the National Academies 210 1$aWashington, District of Columbia :$cNational Academies Press,$d[2013] 210 4$dİ2013 215 $a1 online resource (54 p.) 300 $aErrata sheet inserted. 311 $a0-309-28282-9 320 $aIncludes bibliographical references (pages 31-34). 327 $aResearch framework and statistical modeling approach -- Geography and indexing value -- Evaluation of a geographic value index -- Contributors to geographic variation in Medicare spending -- Discussion -- Limitations. 330 $a"Interim Report of the Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Health Care: Preliminary Committee Observations is designed to provide the committee's preliminary observations for the 113th Congress as it considers further Medicare reform. This report contains only key preliminary observations related primarily to the committee's commissioned analyses of Medicare Parts A (Hospital Insurance program), B (Supplementary Medical Insurance program) and D (outpatient prescription drug benefit), complemented by other empirical investigations. It does not contain any observations related to the committee's commissioned analyses of the commercial insurer population, Medicare Advantage, or Medicaid, which will be presented in the committee's final report after completion of quality-control activities. This interim report excludes conclusions or recommendations related to the committee's consideration of the geographic value index or other payment reforms designed to promote high value care. Additional analyses are forthcoming, which will influence the committee's deliberations. These analyses include an exploration of how Medicare Part C (Medicare Advantage) and commercial spending, utilization, and quality vary compared with, and possibly are influenced by, Medicare Parts A and B spending, utilization, and quality. The committee also is assessing potential biases that may be inherent to Medicare and commercial claims-based measures of health status. Based on this new evidence and continued review of the literature, the committee will confirm the accuracy of the observations presented in this interim report and develop final conclusions and recommendations, which will be published in the committee's final report"--Publisher's description. 606 $aMedicare$vStatistics 606 $aMedicare$xFinance 606 $aMedical care, Cost of$zUnited States 606 $aHealth care reform$zUnited States 608 $aElectronic books. 615 0$aMedicare 615 0$aMedicare$xFinance. 615 0$aMedical care, Cost of 615 0$aHealth care reform 676 $a368.42600973 702 $aNewhouse$b Joseph P. 712 02$aInstitute of Medicine (U.S.).$bBoard on Health Care Services, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910464437103321 996 $aInterim report of the Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care$92458483 997 $aUNINA